金十数据·快讯·· 5 小时前
诺和诺德（Novo Nordisk）减肥药 Frehemgo 获沙特批准，正接受美国 FDA 等监管审查
Novo Nordisk (NVO.N) said its weight-loss drug Frehemgo has been approved in Saudi Arabia and is currently under review by the US FDA and other regulators.
AI 导读
诺和诺德（NVO.N）宣布其减肥药 Frehemgo 已在沙特阿拉伯获批，目前正接受美国 FDA 等多个监管机构的审查。
来源：金十数据·快讯 · jin10.com